Bio-Rad Labs (BIO) Tops Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $280.05 +3.60%
EPS Growth %: -30.7%
Financial Fact:
Net income per share diluted attributable to Bio-Rad: 0.61
Today's EPS Names:
YRD, NNOX, BB, More
EPS Growth %: -30.7%
Financial Fact:
Net income per share diluted attributable to Bio-Rad: 0.61
Today's EPS Names:
YRD, NNOX, BB, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q3 EPS of $0.59, $0.05 better than the analyst estimate of $0.54. Revenue for the quarter came in at $470 million versus the consensus estimate of $495.55 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
- H.B. Fuller (FUL) Tops Q2 EPS by 3c; Offers Outlook
- Goldman Sachs Upgrades Primoris Services Corporation (PRIM) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
